Most GLP-1 users benefit from 0.7 to 1.0 grams of protein per pound of goal body weight per day
While most effects are transient, a significant subset of patients develop persistent intolerance, often leading to misdiagnosis, unnecessary investigations, or premature treatment discontinuation
Whilst effective in improving blood glucose control, emerging evidence links Ozempic and other GLP-1 agonists to an increased risk of gallbladder complications, including gallstones and cholecystitis
Inflammatory Cascade: Venous stasis induced by varicose veins triggers an inflammatory response, perpetuating tissue damage and impeding the reparative processes crucial for ulcer resolution
Many users notice gradual changes over this period, including improvements in digestion, bowel stability, appetite regulation, and how their clothes fit